|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Becouarn Y and Rougier P: Clinical
efficacy of oxaliplatin monotherapy: Phase II trials in advanced
colorectal cancer. Semin Oncol. 25:(Suppl 5). S23–S31. 1998.
|
|
3
|
Ng M, Roy-Chowdhury S, Lum SS, Morgan JW
and Wong JH: The impact of the ratio of positive to total lymph
nodes examined and outcome in colorectal cancer. Am Surg.
75:873–876. 2009.PubMed/NCBI
|
|
4
|
Jemal A, Clegg LX, Ward E, Ries LA, Wu X,
Jamison PM, Wingo PA, Howe HL, Anderson RN and Edwards BK: Annual
report to the nation on the status of cancer, 1975–2001, with a
special feature regarding survival. Cancer. 101:3–27. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sundlisaeter E, Dicko A, Sakariassen PØ,
Sondenaa K, Enger PØ and Bjerkvig R: Lymphangiogenesis in
colorectal cancer - prognostic and therapeutic aspects. Int J
Cancer. 121:1401–1409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Onogawa S, Kitadai Y, Tanaka S, Kuwai T,
Kimura S and Chayama K: Expression of VEGF-C and VEGF-D at the
invasive edge correlates with lymph node metastasis and prognosis
of patients with colorectal carcinoma. Cancer Sci. 95:32–39. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH,
Park JY, Jeon SW, Lee IT, Choi GS and Jun SH: Vascular endothelial
growth factor gene polymorphisms associated with prognosis for
patients with colorectal cancer. Clin Cancer Res. 14:62–66. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parr C and Jiang WG: Quantitative analysis
of lymphangiogenic markers in human colorectal cancer. Int J Oncol.
23:533–539. 2003.PubMed/NCBI
|
|
9
|
Royston D and Jackson DG: Mechanisms of
lymphatic metastasis in human colorectal adenocarcinoma. J Pathol.
217:608–619. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Oncol. 29:(Suppl 16). S15–S18. 2002.
View Article : Google Scholar
|
|
11
|
Hsu JY and Wakelee HA: Monoclonal
antibodies targeting vascular endothelial growth factor: Current
status and future challenges in cancer therapy. BioDrugs.
23:289–304. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chinese Pharmacopoeia Commission, .
Pharmacopoeia of the People's Republic of China. 1. Chinese Medical
Science and Technology Press; Beijing: pp. 573–575. 2010
|
|
13
|
Shen A, Hong F, Liu L, Lin J, Wei L, Cai
Q, Hong Z and Peng J: Pien Tze Huang inhibits the proliferation of
human colon carcinoma cells by arresting G1/S cell cycle
progression. Oncol Lett. 4:767–770. 2012.PubMed/NCBI
|
|
14
|
Lin JM, Wei LH, Chen YQ, Liu XX, Hong ZF,
Sferra TJ and Peng J: Pien Tze Huang induced apoptosis in human
colon cancer HT-29 cells is associated with regulation of the Bcl-2
family and activation of caspase 3. Chin J Integr Med. 17:685–690.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen AL, Hong F, Liu LY, Lin JM, Zhuang
QC, Hong ZF and Peng J: Effects of Pien Tze Huang on angiogenesis
in vivo and in vitro. Chin J Integr Med. 18:431–436. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei L, Chen P, Chen Y, Shen A, Chen H, Lin
W, Hong Z, Sferra TJ and Peng J: Pien Tze Huang suppresses the
stem-like side population in colorectal cancer cells. Mol Med Rep.
9:261–266. 2014.PubMed/NCBI
|
|
17
|
Shen A, Lin J, Chen Y, Lin W, Liu L, Hong
Z, Sferra TJ and Peng J: Pien Tze Huang inhibits tumor angiogenesis
in a mouse model of colorectal cancer via suppression of multiple
cellular pathways. Oncol Rep. 30:1701–1706. 2013.PubMed/NCBI
|
|
18
|
Shen A, Chen H, Chen Y, Lin J, Lin W, Liu
L, Sferra TJ and Peng J: Pien Tze Huang overcomes multidrug
resistance and epithelial-mesenchymal transition in human
colorectal carcinoma cells via suppression of TGF-β pathway. Evid
Based Complement Alternat Med. 2014:6794362014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin W, Zhuang Q, Zheng L, Cao Z, Shen A,
Li Q, Fu C, Feng J and Peng J: Pien Tze Huang inhibits liver
metastasis by targeting TGF-β signaling in an orthotopic model of
colorectal cancer. Oncol Rep. 33:1922–1928. 2015.PubMed/NCBI
|
|
20
|
Grau S: Expression of
lymphangiogenesis-related factors in malignant gliomas. Neurosci
Res. 60:40–49. 2008.PubMed/NCBI
|
|
21
|
Saad RS, Lindner JL, Liu Y and Silverman
JF: Lymphatic vessel density as prognostic marker in esophageal
adenocarcinoma. Am J Clin Pathol. 131:92–98. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu HT, Ma R, Yang QF, Du G and Zhang CJ:
Lymphangiogenic characteristics of triple negativity in
node-negative breast cancer. Int J Surg Pathol. 17:426–431. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oliver G and Detmar M: The rediscovery of
the lymphatic system: Old and new insights into the development and
biological function of the lymphatic vasculature. Genes Dev.
16:773–783. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Caunt M, Mak J, Liang WC, Stawicki S, Pan
Q, Tong RK, Kowalski J, Ho C, Reslan HB, Ross J, et al: Blocking
neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell.
13:331–342. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bahram F and Claesson-Welsh L:
VEGF-mediated signal transduction in lymphatic endothelial cells.
Pathophysiology. 17:253–261. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Girling JE and Rogers PA: Regulation of
endometrial vascular remodelling: Role of the vascular endothelial
growth factor family and the angiopoietin-TIE signalling system.
Reproduction. 138:883–893. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saintigny P, Kambouchner M, Ly M, Gomes N,
Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL,
Bernaudin JF, et al: Vascular endothelial growth factor-C and its
receptor VEGFR-3 in non-small-cell lung cancer: Concurrent
expression in cancer cells from primary tumour and metastatic lymph
node. Lung Cancer. 58:205–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chang L, Kaipainen A and Folkman J:
Lymphangiogenesis new mechanisms. Ann NY Acad Sci. 979:111–119.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su JL, Chen PS, Chien MH, Chen PB, Chen
YH, Lai CC, Hung MC and Kuo ML: Further evidence for expression and
function of the VEGF-C/VEGFR-3 axis in cancer cells. Cancer Cell.
13:557–560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tammela T and Alitalo K:
Lymphangiogenesis: Molecular mechanisms and future promise. Cell.
140:460–476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bergers G, Brekken R, McMahon G, Vu TH,
Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, et al:
Matrix metalloproteinase-9 triggers the angiogenic switch during
carcinogenesis. Nat Cell Biol. 2:737–744. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rojiani MV, Alidina J, Esposito N and
Rojiani AM: Expression of MMP-2 correlates with increased
angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp
Pathol. 3:775–781. 2010.PubMed/NCBI
|
